scispace - formally typeset
M

Manfred S. Green

Researcher at University of Haifa

Publications -  293
Citations -  9435

Manfred S. Green is an academic researcher from University of Haifa. The author has contributed to research in topics: Population & Incidence (epidemiology). The author has an hindex of 50, co-authored 281 publications receiving 8346 citations. Previous affiliations of Manfred S. Green include Tel Aviv University & Centers for Disease Control and Prevention.

Papers
More filters
Journal ArticleDOI

Serum Lipids and Haematological Factors Associated with Resting Heart Rate: The Cordis Study

TL;DR: The role of resting heart rate as a predictor of coronary heart disease may be partly explained by its association with triglycerides, haemoglobin, platelet count and leucocyte count, which may be confounding factors or intervening variables.
Posted ContentDOI

The male excess in case-fatality rates for COVID-19. A meta-analytic study of the age-related differences and consistency over six countries

TL;DR: The sex differences in the CFRs are intriguing and are compatible with the male dominance in the incidence rates of many infectious diseases.
Journal ArticleDOI

Heart rate response to industrial work at different outdoor temperatures with or without temperature control system at the plant

TL;DR: Based on working heart rate, indoor temperature control in industrial plants appears to moderate the cardiovascular strain in working subjects during both cold and hot days.
Journal ArticleDOI

Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel.

TL;DR: The level of immunity to diphtheria among children and adults in Israel was satisfactory, with the exception of individuals aged >50 years, but sporadic cases may occur among individuals lacking basic immunity against the disease.
Journal ArticleDOI

Immune status against diphtheria among immigrants from the former USSR who arrived in Israel during 1990–1991

TL;DR: Immigrants from the former USSR appear to be more susceptible to diphtheria, thus increasing the possibility of clinical disease, and it is recommended that they receive booster doses of diphTheria toxoid.